<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Emerg Infect Dis</journal-id><journal-id journal-id-type="pmc">eid</journal-id><journal-title>Emerging Infectious Diseases</journal-title><issn pub-type="ppub">1080-6040</issn><issn pub-type="epub">1080-6059</issn><publisher><publisher-name>Centers for Disease Control</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">11384521</article-id><article-id pub-id-type="pmc">2631782</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Outbreak of human monkeypox, Democratic Republic of Congo, 1996 to 1997.</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Hutin</surname><given-names>Y. J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Williams</surname><given-names>R. J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Malfait</surname><given-names>P.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Pebody</surname><given-names>R.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Loparev</surname><given-names>V. N.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Ropp</surname><given-names>S. L.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Rodriguez</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Knight</surname><given-names>J. C.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Tshioko</surname><given-names>F. K.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Khan</surname><given-names>A. S.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Szczeniowski</surname><given-names>M. V.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Esposito</surname><given-names>J. J.</given-names></name></contrib></contrib-group><aff>Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA.</aff><pub-date pub-type="ppub"><season>May-Jun</season><year>2001</year></pub-date><volume>7</volume><issue>3</issue><fpage>434</fpage><lpage>438</lpage><abstract><p>Human monkeypox is a zoonotic smallpox-like disease caused by an orthopoxvirus of interhuman transmissibility too low to sustain spread in susceptible populations. In February 1997, 88 cases of febrile pustular rash were identified for the previous 12 months in 12 villages of the Katako-Kombe Health Zone, Democratic Republic of Congo (attack rate = 22 per 1,000; case-fatality rate = 3.7%). Seven were active cases confirmed by virus isolation. Orthopoxvirus- neutralizing antibodies were detected in 54% of 72 patients who provided serum and 25% of 59 wild-caught animals, mainly squirrels. Hemagglutination-inhibition assays and Western blotting detected antibodies in 68% and 73% of patients, respectively. Vaccinia vaccination, which protects against monkeypox, ceased by 1983 after global smallpox eradication, leading to an increase in the proportion of susceptible people.</p></abstract></article-meta></front></article>